Real-World Data on Newly Diagnosed
BRCA1
BRCA2
epidemiological strategy and medical economics database
epidemiology
high-grade epithelial ovarian cancer
overall survival
platinum-based chemotherapy
progression-free survival
real-world data
treatment patterns
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Aug 2022
21 Aug 2022
Historique:
received:
01
07
2022
revised:
09
08
2022
accepted:
18
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
In spite of the frequency and clinical impact of Consecutive patients with Out of the 8021 patients included in the ESME database, 266 patients matching the selection criteria were included. This study reports the largest French multicenter cohort of
Sections du résumé
BACKGROUND
BACKGROUND
In spite of the frequency and clinical impact of
METHODS
METHODS
Consecutive patients with
RESULTS
RESULTS
Out of the 8021 patients included in the ESME database, 266 patients matching the selection criteria were included.
CONCLUSIONS
CONCLUSIONS
This study reports the largest French multicenter cohort of
Identifiants
pubmed: 36011033
pii: cancers14164040
doi: 10.3390/cancers14164040
pmc: PMC9406396
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Oncol. 2021 Oct;32(10):1300-1303
pubmed: 34293462
J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):369-378
pubmed: 30936027
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Eur J Cancer. 2020 Jan;125:22-30
pubmed: 31835235
BMJ Open. 2019 Feb 21;9(2):e023568
pubmed: 30796119
Lancet Oncol. 2015 Aug;16(8):928-36
pubmed: 26115797
Anticancer Res. 2020 Jul;40(7):3905-3913
pubmed: 32620631
Ann Surg. 2021 Feb 01;:
pubmed: 33534229
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78
pubmed: 30306591
Virchows Arch. 2012 Mar;460(3):237-49
pubmed: 22322322
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
ESMO Open. 2021 Jun;6(3):100114
pubmed: 33895695
Cancers (Basel). 2022 Feb 21;14(4):
pubmed: 35205846
J Clin Oncol. 2014 May 1;32(13):1302-8
pubmed: 24637997
J Clin Oncol. 2022 Jun 6;:JCO2201003
pubmed: 35658487
Drug Des Devel Ther. 2017 Dec 06;11:3471-3479
pubmed: 29255348
Eur J Cancer. 2018 May;95:93-101
pubmed: 29655061
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Bull Cancer. 2021 Dec;108(9S1):S13-S21
pubmed: 34955158
Ann Oncol. 2016 Sep;27(9):1725-32
pubmed: 27436849
Cancers (Basel). 2022 Feb 23;14(5):
pubmed: 35267439
Ther Adv Med Oncol. 2022 Feb 26;14:17588359221077082
pubmed: 35237352
Oncology. 2013;85(2):122-7
pubmed: 23941904
Front Pharmacol. 2021 Sep 20;12:711813
pubmed: 34616296
Front Oncol. 2018 Feb 05;8:16
pubmed: 29459887
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
N Engl J Med. 2011 Dec 29;365(26):2473-83
pubmed: 22204724
N Engl J Med. 2011 Dec 29;365(26):2484-96
pubmed: 22204725
Breast. 2021 Feb;55:16-24
pubmed: 33307392
JCO Oncol Pract. 2020 Aug;16(8):e835-e838
pubmed: 32074015
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Eur J Cancer. 2020 Nov;140:163-164
pubmed: 33023786
J Clin Oncol. 2012 Jun 10;30(17):2039-45
pubmed: 22529265
J Clin Oncol. 2020 Oct 20;38(30):3468-3493
pubmed: 32790492
Eur J Cancer. 2020 Apr;129:60-70
pubmed: 32135312
Gynecol Oncol. 2021 Jun;161(3):755-761
pubmed: 33888336
Gynecol Oncol. 2021 Oct;163(1):64-71
pubmed: 34294414
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
Curr Oncol. 2021 Dec 10;28(6):5266-5277
pubmed: 34940079
Gynecol Oncol. 2022 Aug 12;:
pubmed: 35970603